References

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

10.1176/ajp.2006.163.11.1905 · 2006 · External reference

Reproducible brain-wide association studies require thousands of individuals

10.1038/s41586-022-04492-9 · 2022 · External reference

Prediction models for suicide attempts and deaths: a systematic review and simulation

10.1001/jamapsychiatry.2019.0174 · 2019 · External reference

Can we usefully stratify patients according to suicide risk?

2017 · External reference

Assessment of suicide risk in mental health practice: shifting from prediction to therapeutic assessment, formulation, and risk management

10.1016/s2215-0366(22)00232-2 · 2022 · External reference

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement

10.7326/m14-0697 · 2015 · External reference

PROBAST: a tool to assess the risk of bias and applicability of prediction model studies

10.7326/m18-1376 · 2019 · External reference

TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods

10.1136/bmj-2023-078378 · 2024 · External reference

PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods

10.1136/bmj-2024-082505 · 2025 · External reference

Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension

10.1038/s41591-020-1037-7 · 2020 · External reference

Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension

10.1038/s41591-020-1034-x · 2020 · External reference

Decision curve analysis: a novel method for evaluating prediction models

10.1177/0272989x06295361 · 2006 · External reference

Calibration: the Achilles heel of predictive analytics

10.1186/s12916-019-1466-7 · 2019 · External reference

Calibration of risk prediction models: impact on decision-analytic performance

10.1177/0272989x14547233 · 2015 · External reference

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

10.1136/bmj.39489.470347.ad · 2008 · External reference

GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction

2016 · External reference

GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health

10.1016/j.jclinepi.2016.01.032 · 2016 · External reference

GRADE Guidelines 28: use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks

10.1016/j.jclinepi.2019.12.023 · 2020 · External reference

Unresolved reference

2016 · External reference

Precision psychiatry roadmap: towards a biology-informed framework for mental disorders

10.1038/s41380-025-03070-5 · 2025 · External reference

An experimental design for the development of adaptive treatment strategies

10.1002/sim.2022 · 2005 · External reference

The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions

10.1016/j.amepre.2007.01.022 · 2007 · External reference

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers

10.1001/2013.jamapsychiatry.4 · 2013 · External reference

Should inflammation be a specifier for major depression in the DSM-6?

10.1001/jamapsychiatry.2025.0206 · 2025 · External reference

Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder

10.1176/appi.ajp.2016.16050518 · 2017 · External reference

Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals

10.1038/s41380-019-0490-5 · 2020 · External reference

Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study

10.1038/s41386-024-01862-x · 2024 · External reference

Psychotic relapse prediction via biomarker monitoring: a systematic review

10.3389/fpsyt.2024.1463974 · 2024 · External reference

Digital phenotyping for monitoring mental disorders: a systematic review

10.2196/46778 · 2023 · External reference

Privacy-preserving federated model predicting bipolar transition in patients with depression: prediction model development study

10.2196/46165 · 2023 · External reference

The new field of ‘precision psychiatry’

10.1186/s12916-017-0849-x · 2017 · External reference

Candidate biomarkers in psychiatric disorders: state of the field

10.1002/wps.21078 · 2023 · External reference

Clinical prediction models in psychiatry: a systematic review of two decades of progress and challenges

10.1038/s41380-022-01528-4 · 2022 · External reference

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO scale for clinical actionability of molecular targets (ESCAT)

10.1093/annonc/mdy263 · 2018 · External reference

Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a comprehensive profiling program: impact on precision medicine oncology

2022 · External reference

GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research

2017 · External reference